Salix Pharmaceuticals received an FDA approval for Metozolv (metoclopramide), a treatment for diabetic gastroparesis and gastroesophageal reflux disease (GERD). The drug was approved for short-term use, from four to 12 weeks.
There's a reason pharma lags on the programmatic adoption curve: It's a heavily regulated industry, and there are concerns around privacy.
Where are the discussions about applying proven behavior change models or the principles of adult learning and health literacy?
Such intense interest in health content is a rich opportunity to engage, inform, support, and motivate key customer constituencies.